AzTrials
AzTrials

Sarcopenia in ElderlyNCT06986395

Blood Flow Restriction Training for Age-Related Sarcopenia

A study testing Blood Flow Restriction Training (BFRT) and Conventional Resistance Training (CRT) in people with Sarcopenia in Elderly, run by West China Hospital.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Brief Title: Safe Exercise for Age-Related Muscle Loss in Hospitalized Seniors Summary: This study compares two exercise methods to help older hospital patients (age 65+) rebuild muscle strength after being diagnosed with sarcopenia (age-related muscle loss). Read more about this study

Who is it for?
Ages 65 to 100 years
Conditions the study is for
Sarcopenia in Elderly
What is being tested?
Blood Flow Restriction Training (BFRT) and Conventional Resistance Training (CRT)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
No sites listed yet
Study dates
May 2025to 10 Sep 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 100 years
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Hospitalized patients aged ≥65 years
  • Diagnosed with sarcopenia per EWGSOP2019 criteria
  • Acute medical conditions stabilized for ≥4 weeks (e.g., resolved infections, controlled heart failure)

Who cannot join

  • Severe disability (Barthel Index ≤40)
  • Significant cognitive impairment (MMSE ≤18) or major psychiatric disorders (DSM-5 criteria)
  • Contraindications to blood flow restriction training:
  • History/predisposition to deep vein thrombosis
  • Coagulopathy (INR >1.5, platelets <100×10⁹/L)
  • Symptomatic varicose veins (CEAP class C4-C6)
Show all 13Show fewer
  • Uncontrolled hypertension (BP >160/100 mmHg)
  • Chronic lymphedema (ISL stage II-III)
  • Peripheral artery disease (ABI ≤0.7)
  • Active systemic infection (CRP >10 mg/L)
  • Malignancy (except non-melanoma skin cancer)
  • Severe renal impairment (eGFR <30 mL/min/1.73m²)
  • Acute coronary syndrome within 3 months

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Official title: The Efficacy of Blood Flow Restriction Training in Elderly Patients With Sarcopenia.

Brief Title: Safe Exercise for Age-Related Muscle Loss in Hospitalized Seniors

Summary:

Read more

This study compares two exercise methods to help older hospital patients (age 65+) rebuild muscle strength after being diagnosed with sarcopenia (age-related muscle loss). We want to know if using special pressure cuffs during light exercise works better than traditional strength training alone.

Who Can Join:

Hospitalized seniors with stable health conditions Excludes those with severe disabilities, dementia, or certain blood circulation problems

What We'll Do:

40 participants will be randomly assigned to either:

Traditional Training Group:

Uses weights/bands at 65-75% max capacity Arm/leg exercises 3x/week for 4 weeks

Pressure Cuff Training Group:

Uses special cuffs on arms/thighs during lighter exercises (20% max capacity) Same exercise frequency with controlled pressure for safety

What We'll Measure:

Handgrip strength (main test at 0/4/12 weeks) Walking speed, balance tests, quality of life surveys Any side effects like dizziness/nausea

Safety First:

Doctors will check your health before starting. Nurses will monitor every session. We use medical-grade cuffs with safe pressure limits (arm: 80-100mmHg, thigh: 150-200mmHg). You can stop anytime if uncomfortable.

Why This Matters:

This could help hospitalized seniors regain strength faster using gentler exercises. All activities are supervised by rehabilitation specialists at West China Hospital, with ethics committee approval (IRB number required).

Being tested
Blood Flow Restriction Training (BFRT), Conventional Resistance Training (CRT)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Blood Flow Restriction Training (BFRT)Device

    Standard progressive resistance exercise at 65-75% 1RM intensity using weights/elastic bands

  • Conventional Resistance Training (CRT)Other

    Standard progressive resistance exercise at 65-75% 1RM intensity using weights/elastic bands

Study groups in NCT06986395
Study groupRoleWhat they receive
BFRT GroupExperimental"Blood flow restriction training with 20% 1RM loading, pneumatic cuff pressure 80-100mmHg (arms)
Receives: Device: Blood Flow Restriction Training (BFRT)
CRT GroupActive comparatorConventional resistance training at 65-75% 1RM intensity using weights/elastic bands, matched frequency/duration
Receives: Other: Conventional Resistance Training (CRT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Handgrip Strength

    Measured: Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 12)

Secondary outcomes (4)
  1. 6-Meter Walking Speed

    Measured: Baseline (Week 0), Follow-up (Week 12)

  2. Short Physical Performance Battery (SPPB)

    Measured: Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 12)

  3. Timed Up and Go Test (TUG)

    Measured: Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 12)

  4. MBI

    Measured: Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 12)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 May 2025
  2. Study startMay 2025 (estimated)
  3. Primary completion1 Sep 2025 (estimated)
  4. Study completion10 Sep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06986395
Sponsor's protocol ID
20241201
Status last verified
Jan 2025
First submitted
20 May 2025
Last updated
23 May 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Blood Flow Restriction Training (BFRT) and Conventional Resistance Training (CRT) in people with Sarcopenia in Elderly, run by West China Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 23 May 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact yu liang (+86 13982250862, 1536569213@qq.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Handgrip Strength (time frame: Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 12)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in